Stock Quote

BioForm Medical, Inc. (BFRM.W) (NASD ADF)
As of  12 Nov 2009
3.63USD
Price Change
-0.26
Percent Change
-6.68%
 
$3.63
12 Nov 2009
-6.68%
$3.89
$3.63
400
$3.63
$3.63
$4.20
$0.74
1.57
120,658

Research Another Stock: Symbol Look-up
No news stories for this company within the last 30 days.
Bioform Medical: Warming Up or Cooling Off?
Thursday, 19 Nov 2009 07:15am EST(The Motley Fool) 
Kopin, Cardionet: Early Volume Plays
Monday, 2 Nov 2009 08:37am EST(The Street) 
BioForm Medical, Inc. F4Q09 (Qtr End 06/30/09) Earnings Call Transcript
Wednesday, 19 Aug 2009 09:51pm EDT(Seeking Alpha) 
Closing Update for Thursday, June 16
Thursday, 16 Jul 2009 04:21pm EDT(Seeking Alpha) 
FDA Calendar Updates: Zogenix, Aradigm, Medtronic, BioForm, Cornerstone
Thursday, 16 Jul 2009 12:01pm EDT(Seeking Alpha) 
 
Name Current Position Compensation
Basta, Steven Chief Executive Officer, Director 1,126,650
Condon, Dennis President, Chief Business Officer, Director 864,635
Lwee, Frederick Principal Financial Officer, Vice President - Finance, Controller, Assistant Secretary 263,397

Profile

BioForm Medical, Inc. (BioForm) is a medical aesthetics company focused on developing and commercializing products that are used by physicians to enhance a patient’s appearance. The Company’s product is RADIESSE, an injectable dermal filler designed to provide aesthetic improvement for patients.... Full Description

Company Address

BioForm Medical, Inc.
1875 South Grant Street
Suite 200
San Mateo   CA   94402
P: +1650.2864000
F: +1650.2864090

Analyst Research

Performance of Key Competitors

Company Price Change
Allergan, Inc. $58.66 +0.04
Medicis Pharmaceutical Corporation $23.97 +0.48
Q-Med AB kr43.30 -0.30
  BFRM.W Industry
P/E(TTM) -- 3.76
P/S(TTM) 2.47 0.51
ROI(TTM) -28.96 2.54
ROE(TTM) -28.98 4.01
Consensus Recommendation Buy
EPS Est. (Current Period) -0.03
EPS Est. (Current Year) -0.52
Total Revenue $19.17M
Net Income $-1.88M
EPS $-0.04